Cardinal Health vs McKesson
McKesson is the larger business, with $403.43bn of revenue in fiscal 2026 against $254.25bn for Cardinal Health (1.6 times as much). Cardinal Health grew faster (14.2% against 12.4%). McKesson kept more of each dollar of sales as profit: a net margin of 1.2% against 0.7%.
| Latest fiscal year | Cardinal HealthCAH, 2026 | McKessonMCK, 2026 |
|---|---|---|
| Revenue | $254.25bn | $403.43bn |
| Revenue growth | 14.2% | 12.4% |
| Net income | $1.71bn | $4.76bn |
| Operating margin | 1.0% | 1.5% |
| Net margin | 0.7% | 1.2% |
| Return on equity | — | — |
| Free cash flow | $4.53bn | $5.72bn |
| Cash | $4.86bn | $3.98bn |
| Total debt | $8.89bn | $6.53bn |
| Debt to equity | — | — |
| Dividend per share | $2.04 | $3.17 |
| Dividend yield | 0.8% | 0.3% |
| Share buybacks | $1.36bn | $4.75bn |
| Employees | 63,900 | 43,000 |
| Market value | $60.15bn | $119.67bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 40 (Weak) | 43 (Weak) |
| Insider trades, 12 months | 0 buys, 35 sales | 0 buys, 19 sales |